| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.2B | $1.1B | 5.9% | 14.7% |
| Op. Income | $41M | $37M | -$1M | 10.3% | 3512.3% |
| Gross Margin | 48.6% | 48.1% | 50.0% | 0.5pp | -1.4pp |
| Net Margin | 2.9% | 1.8% | -0.9% | 1.0pp | 3.7pp |
| EPS (Diluted) | $0.23 | $0.14 | $-0.06 | 64.3% | 476.4% |
| Free Cash Flow | $248M | $263M | $189M | -6.1% | 30.9% |
| Item | Amount |
|---|---|
| REVENUE | $1.3B |
| Cost of Revenue | $668M |
| GROSS PROFIT | $632M |
| R&D Expenses | $262M |
| Selling & Marketing | $221M |
| General & Administrative | $108M |
| SG&A Expenses | $329M |
| Other Expenses | $0 |
| Operating Expenses | $591M |
| Cost & Expenses | $1.3B |
| OPERATING INCOME | $41M |
| Interest Income | $16M |
| Interest Expense | $0 |
| Other Income/Expenses | -$8M |
| INCOME BEFORE TAX | $33M |
| Income Tax Expense | -$5M |
| Net Income from Continuing Ops | $37M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $37M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $37M |
| D&A | $38M |
| EBIT | $33M |
| EBITDA | $71M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $1.3B |
| Cost of Revenue | $668M |
| GROSS PROFIT | $632M |
| R&D Expenses | $262M |
| Selling & Marketing | $221M |
| General & Administrative | $108M |
| SG&A Expenses | $329M |
| Other Expenses | $0 |
| Operating Expenses | $591M |
| Cost & Expenses | $1.3B |
| OPERATING INCOME | $41M |
| Interest Income | $16M |
| Interest Expense | $0 |
| Other Income/Expenses | -$8M |
| INCOME BEFORE TAX | $33M |
| Income Tax Expense | -$5M |
| Net Income from Continuing Ops | $37M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $37M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $37M |
| D&A | $38M |
| EBIT | $33M |
| EBITDA | $71M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $37M |
| Depreciation & Amortization | $48M |
| Stock-Based Compensation | $158M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $57M |
| Change in Working Capital | -$37M |
| OPERATING CASH FLOW | $264M |
| Capital Expenditure | -$16M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$371M |
| Sales/Maturities of Investments | $226M |
| Other Investing Activities | -$38M |
| NET CASH FROM INVESTING | -$162M |
| Net Debt Issuance | -$1M |
| Common Stock Repurchased | -$347M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$75.0K |
| NET CASH FROM FINANCING | -$348M |
| FREE CASH FLOW | $248M |
| Net Change in Cash | -$234M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $735M |
| Short-Term Investments | $1.7B |
| Net Receivables | $613M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $3.5B |
| PP&E (Net) | $223M |
| Goodwill | $5.2B |
| Intangible Assets | $157M |
| Long-Term Investments | $413M |
| Tax Assets | $0 |
| Other Non-Current Assets | $199M |
| TOTAL NON-CURRENT ASSETS | $6.2B |
| TOTAL ASSETS | $9.7B |
| Account Payables | $40M |
| Short-Term Debt | $0 |
| Deferred Revenue | $159M |
| Other Current Liabilities | $108M |
| TOTAL CURRENT LIABILITIES | $742M |
| Long-Term Debt | $992M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $15M |
| TOTAL NON-CURRENT LIABILITIES | $1.1B |
| TOTAL LIABILITIES | $1.8B |
| Common Stock | $152.0K |
| Additional Paid-In Capital | $16.0B |
| Retained Earnings | -$8.1B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $23M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $7.9B |
| Minority Interest | $0 |
| TOTAL EQUITY | $7.9B |
| TOTAL LIABILITIES & EQUITY | $9.7B |
| Total Debt | $1.1B |
| Net Debt | $360M |
